↓ Skip to main content

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

Overview of attention for article published in European Journal of Cancer (1965), January 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
patent
9 patents

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up
Published in
European Journal of Cancer (1965), January 2005
DOI 10.1016/j.ejca.2004.06.030
Pubmed ID
Authors

Lisa Rydén, Per-Ebbe Jönsson, Gunilla Chebil, Monika Dufmats, Mårten Fernö, Karin Jirström, Ann-Christin Källström, Göran Landberg, Olle Stål, Sten Thorstenson, Bo Nordenskjöld, On behalf of the South Swedish and South-East Swedish Breast Cancer Groups

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 4%
Sweden 1 4%
Unknown 22 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 21%
Student > Master 5 21%
Student > Ph. D. Student 3 13%
Professor > Associate Professor 3 13%
Student > Postgraduate 2 8%
Other 5 21%
Unknown 1 4%
Readers by discipline Count As %
Medicine and Dentistry 10 42%
Agricultural and Biological Sciences 3 13%
Computer Science 3 13%
Nursing and Health Professions 2 8%
Psychology 2 8%
Other 3 13%
Unknown 1 4%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2022.
All research outputs
#3,415,510
of 25,374,917 outputs
Outputs from European Journal of Cancer (1965)
#966
of 6,871 outputs
Outputs of similar age
#9,741
of 151,230 outputs
Outputs of similar age from European Journal of Cancer (1965)
#5
of 39 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,871 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 151,230 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.